article Open AccessTop 1% cited

European League Against Rheumatism (EULAR) recommendations for the management of psoriatic arthritis with pharmacological therapies: 2015 update

Annals of the Rheumatic Diseases · 2016 · Vol. 75(3) · pp. 499–510

Laure Gossec✉(Sorbonne Université)Josef S Smolen(Klinik Hietzing)Sofía Ramiro(Leiden University Medical Center)M. De WitMaurizio Cutolo(University of Genoa)Maxime Dougados(Délégation Paris 5)Paul Emery(University of Leeds)R. Landewé(Amsterdam UMC Location University of Amsterdam)Susan OliverDaniel Aletaha(Medical University of Vienna)Neil BetteridgeJürgen Braun(Rheumazentrum Ruhrgebiet)Gerd R Burmester(Charité - Universitätsmedizin Berlin)Juan D. Cañete(Hospital Clínic de Barcelona)Nemanja Damjanov(University of Belgrade)Oliver FitzGerald(University College Dublin)Emma Haglund(Lund University)Philip Helliwell(University of Leeds)T. K. Kvien(Diakonhjemmet Hospital)Rik Lories(KU Leuven)Thomas A. Luger(University Hospital Münster)Mara Maccarone(Psoriasis Association)Helena Marzo‐Ortega(University of Leeds)Dennis McGonagle(University of Leeds)Iain B. McInnes(University of Glasgow)Ignazio Olivieri(Ospedale Madonna Delle Grazie)Karel Pavelká(Charles University)Georg Schett(Friedrich-Alexander-Universität Erlangen-Nürnberg)Joachim Sieper(Charité - Universitätsmedizin Berlin)Filip Van den Bosch(Ghent University Hospital)Douglas J. Veale(St. Vincent's University Hospital)J. Wollenhaupt(Schön Klinik Hamburg Eilbek)A. Zink(German Rheumatism Research Centre)Désirée van der Heijde(Leiden University Medical Center)

View via DOI Full-text PDF

Spondyloarthritis Studies and Treatments Rheumatoid Arthritis Research and Therapies Psoriasis: Treatment and PathogenesisMedicineSecukinumabPsoriatic arthritisApremilastUstekinumabRheumatismIntensive care medicineDiseaseAntirheumatic AgentsTNF inhibitor

MeSH terms

AlgorithmsAnti-Inflammatory Agents, Non-SteroidalEuropeGlucocorticoidsHumansRheumatologySocieties, MedicalArthritis, PsoriaticAntirheumatic AgentsDisease Management

Citations

910

FWCI

142.20

field-weighted impact

References

111

Percentile

100%

vs. same field & year

Citations per year

Cited by